We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VFC icon
301
VF Corp
VFC
$6.68B
$1.07M 0.02%
15,383
– –
TD icon
302
Toronto Dominion Bank
TD
$198B
$1.06M 0.02%
18,083
+6,730
+59% +$384K
DELL icon
303
Dell
DELL
$283B
$1.06M 0.02%
46,286
-852
-2% -$19.3K
BAC icon
304
Bank of America
BAC
$435B
$991K 0.01%
33,554
+4,500
+15% +$124K
VNQ icon
305
Vanguard Real Estate ETF
VNQ
$39.9B
$971K 0.01%
11,700
-500
-4% -$41.9K
WEC icon
306
WEC Energy
WEC
$37.7B
$938K 0.01%
14,130
-75
-0.5% -$5.03K
SPY icon
307
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$930K 0.01%
3,484
– –
SPGI icon
308
S&P Global
SPGI
$126B
$913K 0.01%
5,388
-130
-2% -$21.2K
BRK.A icon
309
Berkshire Hathaway Class A
BRK.A
$1.07T
$893K 0.01%
3
– –
ROK icon
310
Rockwell Automation
ROK
$51.4B
$884K 0.01%
4,500
– –
BIIB icon
311
Biogen
BIIB
$29.9B
$858K 0.01%
2,694
– –
VEA icon
312
Vanguard FTSE Developed Markets ETF
VEA
$226B
$846K 0.01%
18,857
-667
-3% -$29.5K
EWJ icon
313
iShares MSCI Japan ETF
EWJ
$21.6B
$811K 0.01%
13,537
-20,500
-60% -$1.2M
IWD icon
314
iShares Russell 1000 Value ETF
IWD
$82B
$808K 0.01%
6,497
– –
PH icon
315
Parker-Hannifin
PH
$125B
$783K 0.01%
3,925
– –
NEE icon
316
NextEra Energy
NEE
$187B
$779K 0.01%
19,948
+2,760
+16% +$107K
NSC icon
317
Norfolk Southern
NSC
$78.8B
$764K 0.01%
5,271
-20
-0.4% -$2.69K
MA icon
318
Mastercard
MA
$477B
$753K 0.01%
4,977
-250
-5% -$37.2K
IVV icon
319
iShares Core S&P 500 ETF
IVV
$869B
$725K 0.01%
2,698
-8
-0.3% -$2.1K
VTV icon
320
Vanguard Value ETF
VTV
$189B
$722K 0.01%
6,787
-124
-2% -$12.8K
WMT icon
321
Walmart Inc
WMT
$871B
$694K 0.01%
21,078
+57
+0.3% +$1.74K
LLY icon
322
Eli Lilly
LLY
$1.07T
$648K 0.01%
7,677
-260
-3% -$22.1K
EPP icon
323
iShares MSCI Pacific ex Japan ETF
EPP
$2.18B
$626K 0.01%
13,100
-10,500
-44% -$496K
K
324
DELISTED
Kellanova
K
$624K 0.01%
9,771
-54
-0.5% -$3.25K
UL icon
325
Unilever
UL
$131B
$622K 0.01%
9,994
+3,716
+59% +$235K
11 12
13
14 15

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.